Literature DB >> 25231295

Establishment and characterization of an air-liquid canine corneal organ culture model to study acute herpes keratitis.

Rebecca M Harman1, Leen Bussche1, Eric C Ledbetter2, Gerlinde R Van de Walle3.   

Abstract

UNLABELLED: Despite the clinical importance of herpes simplex virus (HSV)-induced ocular disease, the underlying pathophysiology of the disease remains poorly understood, in part due to the lack of adequate virus-natural-host models in which to study the cellular and viral factors involved in acute corneal infection. We developed an air-liquid canine corneal organ culture model and evaluated its susceptibility to canine herpesvirus type 1 (CHV-1) in order to study ocular herpes in a physiologically relevant natural host model. Canine corneas were maintained in culture at an air-liquid interface for up to 25 days, and no degenerative changes were observed in the corneal epithelium during cultivation using histology for morphometric analyses, terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays, and transmission electron microscopy (TEM). Next, canine corneas were inoculated with CHV-1 for 48 h, and at that time point postinfection, viral plaques could be visualized in the corneal epithelium and viral DNA copies were detected in both the infected corneas and culture supernatants. In addition, we found that canine corneas produced proinflammatory cytokines in response to CHV-1 infection similarly to what has been described for HSV-1. This emphasizes the value of our model as a virus-natural-host model to study ocular herpesvirus infections. IMPORTANCE: This study is the first to describe the establishment of an air-liquid canine corneal organ culture model as a useful model to study ocular herpesvirus infections. The advantages of this physiologically relevant model include the fact that (i) it provides a system in which ocular herpes can be studied in a virus-natural-host setting and (ii) it reduces the number of experimental animals needed. In addition, this long-term explant culture model may also facilitate research in other fields where noninfectious and infectious ocular diseases of dogs and humans are being studied.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231295      PMCID: PMC4248983          DOI: 10.1128/JVI.02135-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Ultrastructure of human organ-cultured cornea. II. Stroma and epithelium.

Authors:  D L Van Horn; D J Doughman; J E Harris; G E Miller; R Lindstrom; R A Good
Journal:  Arch Ophthalmol       Date:  1975-04

2.  Air/liquid corneal organ culture: a light microscopic study.

Authors:  N R Richard; J A Anderson; J L Weiss; P S Binder
Journal:  Curr Eye Res       Date:  1991-08       Impact factor: 2.424

Review 3.  Viruses and apoptosis.

Authors:  V O'Brien
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

Review 4.  Canine herpesvirus-1 ocular diseases of mature dogs.

Authors:  E C Ledbetter
Journal:  N Z Vet J       Date:  2013-02-26       Impact factor: 1.628

5.  Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells.

Authors:  Hui Li; Jing Zhang; Ashok Kumar; Mei Zheng; Sally S Atherton; Fu-Shin X Yu
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

6.  Culture of feline corneal epithelial cells and infection with feline herpesvirus-1 as an investigative tool.

Authors:  Lynne S Sandmeyer; Charlotte B Keller; Dorothee Bienzle
Journal:  Am J Vet Res       Date:  2005-02       Impact factor: 1.156

7.  In vitro model for corneal wound healing; organ-cultured human corneas.

Authors:  H B Collin; J A Anderson; N R Richard; P S Binder
Journal:  Curr Eye Res       Date:  1995-05       Impact factor: 2.424

8.  Development of a three-dimensional organ culture model for corneal wound healing and corneal transplantation.

Authors:  Bojun Zhao; Leanne J Cooper; Arun Brahma; Sheila MacNeil; Stephen Rimmer; Nigel J Fullwood
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

9.  Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis.

Authors:  Roger Maes
Journal:  ISRN Vet Sci       Date:  2012-11-14

Review 10.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
View more
  5 in total

1.  Development of a novel ex vivo equine corneal model.

Authors:  Todd L Marlo; Elizabeth A Giuliano; Ajay Sharma; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2016-07-29       Impact factor: 1.644

2.  Canid herpesvirus 1 Preferentially Infects Polarized Madin-Darby Canine Kidney Cells from the Basolateral Surface.

Authors:  Mohamed Eisa; Samar Micky; Angela Pearson
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

3.  Ex vivo Caprine Model to Study Virulence Factors in Keratitis.

Authors:  Swati N Madhu; Kartik Kumar Jha; Annapoorna P Karthyayani; Devarshi Urvish Gajjar
Journal:  J Ophthalmic Vis Res       Date:  2018 Oct-Dec

Review 4.  New Paradigms for the Study of Ocular Alphaherpesvirus Infections: Insights into the Use of Non-Traditional Host Model Systems.

Authors:  Matthew R Pennington; Eric C Ledbetter; Gerlinde R Van de Walle
Journal:  Viruses       Date:  2017-11-18       Impact factor: 5.048

5.  Assessment of Cidofovir for Treatment of Ocular Bovine Herpesvirus-1 Infection in Cattle Using an Ex-Vivo Model.

Authors:  Christopher R Alling; Chin-Chi Liu; Ingeborg M Langohr; Muzammel Haque; Renee T Carter; Rose E Baker; Andrew C Lewin
Journal:  Viruses       Date:  2021-10-18       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.